| Serial Number | 79141948 |
| Word Mark | FKB |
| Filing Date | Friday, November 15, 2013 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, February 11, 2022 |
| Registration Number | 4779408 |
| Registration Date | Tuesday, July 28, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 12, 2015 |
| Goods and Services | Custom manufacture of pharmaceuticals |
| Goods and Services | Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases; Pharmaceutical preparations for use in connection with humans for the treatment of parasitic diseases; Pharmaceutical preparations for use in connection with humans for the prevention of parasitic diseases; Pharmaceutical preparations for use in connection with humans for the treatment of neoplasms; Pharmaceutical preparations for use in connection with humans for the prevention of neoplasms; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the blood; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the blood; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of blood-forming organs; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of blood-forming organs; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of certain disorders involving the immune mechanism; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of certain disorders involving the immune mechanism; Pharmaceutical preparations for use in connection with humans for the treatment of endocrine diseases; Pharmaceutical preparations for use in connection with humans for the prevention of endocrine diseases; Pharmaceutical preparations for use in connection with humans for the treatment of nutritional diseases; Pharmaceutical preparations for use in connection with humans for the prevention of nutritional diseases; Pharmaceutical preparations for use in connection with humans for the treatment of metabolic diseases; Pharmaceutical preparations for use in connection with humans for the prevention of metabolic diseases; Pharmaceutical preparations for use in connection with humans for the treatment of mental disorders; Pharmaceutical preparations for use in connection with humans for the prevention of mental disorders ; Pharmaceutical preparations for use in connection with humans for the treatment of behavioural disorders; Pharmaceutical preparations for use in connection with humans for the prevention of behavioural disorders; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the nervous system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the nervous system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the eye; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the eye; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of eye adnexa; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of eye adnexa; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the ear; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the ear; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the mastoid process; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the mastoid process; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the circulatory system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the circulatory system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the respiratory system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the respiratory system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the digestive system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the digestive system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the skin; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the skin; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of subcutaneous tissue; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of subcutaneous tissue; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the musculoskeletal system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the musculoskeletal system; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the connective tissue; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the connective tissue; Pharmaceutical preparations for use in connection with humans for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for use in connection with humans for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases and diabetes occurred in pregnancy; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases and diabetes occurred in pregnancy; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in childbirth; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in childbirth; Pharmaceutical preparations for use in connection with humans for the treatment of infectious diseases occurred in the puerperium; Pharmaceutical preparations for use in connection with humans for the prevention of infectious diseases occurred in the puerperium; Pharmaceutical preparations for use in connection with humans for the treatment of nutritional deficiency conditions originating in the perinatal period; Pharmaceutical preparations for use in connection with humans for the prevention of nutritional deficiency conditions originating in the perinatal period; Pharmaceutical preparations for use in connection with humans for the treatment of congenital malformations; Pharmaceutical preparations for use in connection with humans for the prevention of congenital malformations; Pharmaceutical preparations for use in connection with humans for the treatment of deformations; Pharmaceutical preparations for use in connection with humans for the prevention of deformations; Pharmaceutical preparations for use in connection with humans for the treatment of chromosomal abnormalities; Pharmaceutical preparations for use in connection with humans for the prevention of chromosomal abnormalities; Prescribed pharmaceutical preparations for the treatment of infectious diseases; Prescribed pharmaceutical preparations for the prevention of infectious diseases; Prescribed pharmaceutical preparations for the treatment of parasitic diseases; Prescribed pharmaceutical preparations for the prevention of parasitic diseases; Prescribed pharmaceutical preparations for the treatment of neoplasms; Prescribed pharmaceutical preparations for the prevention of neoplasms; Prescribed pharmaceutical preparations for the treatment of diseases of the blood; Prescribed pharmaceutical preparations for the prevention of diseases of the blood Prescribed pharmaceutical preparations for the treatment of diseases of blood-forming organs; Prescribed pharmaceutical preparations for the prevention of diseases of blood-forming organs; Prescribed pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; Prescribed pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; Prescribed pharmaceutical preparations for the treatment of endocrine diseases; Prescribed pharmaceutical preparations for the prevention of endocrine diseases; Prescribed pharmaceutical preparations for the treatment of nutritional diseases; Prescribed pharmaceutical preparations for the prevention of nutritional diseases; Prescribed pharmaceutical preparations for the treatment of metabolic diseases; Prescribed pharmaceutical preparations for the prevention of metabolic diseases; Prescribed pharmaceutical preparations for the treatment of mental disorders; Prescribed pharmaceutical preparations for the prevention of mental disorders; Prescribed pharmaceutical preparations for the treatment of behavioural disorders; Prescribed pharmaceutical preparations for the prevention of behavioural disorders; Prescribed pharmaceutical preparations for the treatment of diseases of the nervous system; Prescribed pharmaceutical preparations for the prevention of diseases of the nervous system; Prescribed pharmaceutical preparations for the treatment of diseases of the eye; Prescribed pharmaceutical preparations for the prevention of diseases of the eye; Prescribed pharmaceutical preparations for the treatment of diseases of eye adnexa; Prescribed pharmaceutical preparations for the prevention of diseases of eye adnexa; Prescribed pharmaceutical preparations for the treatment of diseases of the ear; Prescribed pharmaceutical preparations for the prevention of diseases of the ear; Prescribed pharmaceutical preparations for the treatment of diseases of the mastoid process; Prescribed pharmaceutical preparations for the prevention of diseases of the mastoid process; Prescribed pharmaceutical preparations for the treatment of diseases of the circulatory system; Prescribed pharmaceutical preparations for the prevention of diseases of the circulatory system; Prescribed pharmaceutical preparations for the treatment of diseases of the respiratory system; Prescribed pharmaceutical preparations for the prevention of diseases of the respiratory system; Prescribed pharmaceutical preparations for the treatment of diseases of the digestive system; Prescribed pharmaceutical preparations for the prevention of diseases of the digestive system; Prescribed pharmaceutical preparations for the treatment of diseases of the skin; Prescribed pharmaceutical preparations for the prevention of diseases of the skin; Prescribed pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; Prescribed pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; Prescribed pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; Prescribed pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; Prescribed pharmaceutical preparations for the treatment of diseases of the connective tissue; Prescribed pharmaceutical preparations for the prevention of diseases of the connective tissue; Prescribed pharmaceutical preparations for the treatment of diseases of the genitourinary system; Prescribed pharmaceutical preparations for the prevention of diseases of the genitourinary system; Prescribed pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; Prescribed pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; Prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; Prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; Prescribed pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; Prescribed pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; Prescribed pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; Prescribed pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; Prescribed pharmaceutical preparations for the treatment of congenital malformations; Prescribed pharmaceutical preparations for the prevention of congenital malformations; Prescribed pharmaceutical preparations for the treatment of deformations; Prescribed pharmaceutical preparations for the prevention of deformations; Prescribed pharmaceutical preparations for the treatment of chromosomal abnormalities; Prescribed pharmaceutical preparations for the prevention of chromosomal abnormalities; Biological pharmaceutical preparations for the treatment of infectious diseases; Biological pharmaceutical preparations for the prevention of infectious diseases; Biological pharmaceutical preparations for the treatment of parasitic diseases; Biological pharmaceutical preparations for the prevention of parasitic diseases; Biological pharmaceutical preparations for the treatment of neoplasms; Biological pharmaceutical preparations for the prevention of neoplasms; Biological pharmaceutical preparations for the treatment of diseases of the blood; Biological pharmaceutical preparations for the prevention of diseases of the blood; Biological pharmaceutical preparations for the treatment of diseases of blood-forming organs; Biological pharmaceutical preparations for the prevention of diseases of blood-forming organs; Biological pharmaceutical preparations for the treatment of diseases of certain disorders involving the immune mechanism; Biological pharmaceutical preparations for the prevention of diseases of certain disorders involving the immune mechanism; Biological pharmaceutical preparations for the treatment of endocrine diseases; Biological pharmaceutical preparations for the prevention of endocrine diseases; Biological pharmaceutical preparations for the treatment of nutritional diseases; Biological pharmaceutical preparations for the prevention of nutritional diseases; Biological pharmaceutical preparations for the treatment of metabolic diseases; Biological pharmaceutical preparations for the prevention of metabolic diseases; Biological pharmaceutical preparations for the treatment of mental disorders; Biological pharmaceutical preparations for the prevention of mental disorders; Biological pharmaceutical preparations for the treatment of behavioural disorders; Biological pharmaceutical preparations for the prevention of behavioural disorders; Biological pharmaceutical preparations for the treatment of diseases of the nervous system; Biological pharmaceutical preparations for the prevention of diseases of the nervous system; Biological pharmaceutical preparations for the treatment of diseases of the eye; Biological pharmaceutical preparations for the prevention of diseases of the eye; Biological pharmaceutical preparations for the treatment of diseases of eye adnexa; Biological pharmaceutical preparations for the prevention of diseases of eye adnexa; Biological pharmaceutical preparations for the treatment of diseases of the ear; Biological pharmaceutical preparations for the prevention of diseases of the ear; Biological pharmaceutical preparations for the treatment of diseases of the mastoid process; Biological pharmaceutical preparations for the prevention of diseases of the mastoid process; Biological pharmaceutical preparations for the treatment of diseases of the circulatory system; Biological pharmaceutical preparations for the prevention of diseases of the circulatory system; Biological pharmaceutical preparations for the treatment of diseases of the respiratory system; Biological pharmaceutical preparations for the prevention of diseases of the respiratory system; Biological pharmaceutical preparations for the treatment of diseases of the digestive system; Biological pharmaceutical preparations for the prevention of diseases of the digestive system; Biological pharmaceutical preparations for the treatment of diseases of the skin; Biological pharmaceutical preparations for the prevention of diseases of the skin; Biological pharmaceutical preparations for the treatment of diseases of subcutaneous tissue; Biological pharmaceutical preparations for the prevention of diseases of subcutaneous tissue; Biological pharmaceutical preparations for the treatment of diseases of the musculoskeletal system; Biological pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; Biological pharmaceutical preparations for the treatment of diseases of the connective tissue; Biological pharmaceutical preparations for the prevention of diseases of the connective tissue; Biological pharmaceutical preparations for the treatment of diseases of the genitourinary system; Biological pharmaceutical preparations for the prevention of diseases of the genitourinary system; Biological pharmaceutical preparations for the treatment of infectious diseases and diabetes occurred in pregnancy; Biological pharmaceutical preparations for the prevention of infectious diseases and diabetes occurred in pregnancy; Biological pharmaceutical preparations for the treatment of infectious diseases occurred in childbirth; Biological pharmaceutical preparations for the prevention of infectious diseases occurred in childbirth; Biological pharmaceutical preparations for the treatment of infectious diseases occurred in the puerperium; Biological pharmaceutical preparations for the prevention of infectious diseases occurred in the puerperium; Biological pharmaceutical preparations for the treatment of nutritional deficiency conditions originating in the perinatal period; Biological pharmaceutical preparations for the prevention of nutritional deficiency conditions originating in the perinatal period; Biological pharmaceutical preparations for the treatment of congenital malformations; Biological pharmaceutical preparations for the prevention of congenital malformations; Biological pharmaceutical preparations for the treatment of deformations; Biological pharmaceutical preparations for the prevention of deformations; Biological pharmaceutical preparations for the treatment of chromosomal abnormalities; Biological pharmaceutical preparations for the prevention of chromosomal abnormalities;bandages for dressings |
| Goods and Services | Providing information concerning commercial sales in the field of pharmaceuticals |
| Goods and Services | Pharmaceutical information services provided via the Internet, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services provided via the Internet; providing medical information |
| Goods and Services | Apparatus for drug administration, namely, drug delivery systems, injector, autoinjector; Therapeutic inhalers, sold empty; High frequency electromagnetic therapy apparatus; Oxygen inhalaters for therapeutic purposes; Ultraviolet radiator units for therapeutic purposes; Defibrillators; Pneumothorax apparatus, namely, medical apparatus for diagnosing or treating respiratory conditions; Heart pacemakers; Mercury arc lamp units for therapeutic purposes; Infrared radiator units for therapeutic purposes; Puncture apparatus for therapeutic purposes, namely, medical devices for closing wounds; Lavage apparatus for therapeutic purposes, namely, apparatus for washing out body cavities; Carbon arc lamp units for therapeutic purposes; Injection syringes, syringe barrels; Injection needles; Infusion apparatus for therapeutic purposes, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; Ultrasonic therapy machines and apparatus; Short wave therapy machines and apparatus; Therapeutic bath apparatus and instruments, namely, appliances for washing body cavities; Massage apparatus for medical purposes; Low frequency electric therapy apparatus; Static electric therapy apparatus; Dialyzers, namely, blood component separation apparatus for medical purposes; Acupuncture needles; Sprayers for medical purposes, namely, drug delivery sprayers sold empty; Suture apparatus for medical purposes, namely, suture needles and suture materials; Radioisotope therapy apparatus and instruments; Incubators for babies; Blood transfusion apparatus; Containers and trays specially designed for transporting and holding pharmaceuticals; Injection device for pharmaceuticals; Injection instruments without needles; Injection instruments with needles |
| Goods and Services | Pharmaceutical research; pharmaceutical development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 11, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 11, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 11, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 11, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 11, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, February 11, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | tokyo 100-8185 JP |
| Party Name | FUJIFILM KYOWA KIRIN BIOLOGICS; Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | FUJIFILM KYOWA KIRIN BIOLOGICS; Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Event Date | Event Description |
| Friday, October 6, 2023 | INTERNATIONAL REGISTRATION RENEWED |
| Tuesday, June 6, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, April 14, 2023 | GENERIC MADRID TRANSACTION SENT TO IB |
| Friday, April 14, 2023 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Friday, April 14, 2023 | GENERIC MADRID TRANSACTION CREATED |
| Sunday, January 15, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, October 11, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Monday, May 30, 2022 | NOTIFICATION PROCESSED BY IB |
| Monday, March 21, 2022 | REFUSAL PROCESSED BY IB |
| Friday, February 11, 2022 | CANCELLED SECTION 71 |
| Sunday, January 31, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, December 15, 2015 | GENERIC MADRID TRANSACTION SENT TO IB |
| Tuesday, December 15, 2015 | GENERIC MADRID TRANSACTION CREATED |
| Wednesday, October 28, 2015 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 20, 2015 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Friday, October 9, 2015 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, July 28, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Friday, July 17, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, July 1, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, July 1, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, May 12, 2015 | PUBLISHED FOR OPPOSITION |
| Friday, May 8, 2015 | NOTIFICATION PROCESSED BY IB |
| Wednesday, April 22, 2015 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 22, 2015 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 22, 2015 | NOTICE OF PUBLICATION |
| Tuesday, April 7, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, April 7, 2015 | ASSIGNED TO LIE |
| Friday, March 20, 2015 | EXAMINERS AMENDMENT MAILED |
| Thursday, March 19, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, March 19, 2015 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, March 19, 2015 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, February 6, 2015 | FINAL REFUSAL MAILED |
| Thursday, February 5, 2015 | FINAL REFUSAL WRITTEN |
| Friday, January 16, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 15, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 15, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 22, 2014 | NON-FINAL ACTION MAILED |
| Monday, July 21, 2014 | NON-FINAL ACTION WRITTEN |
| Monday, June 30, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 30, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 19, 2014 | ASSIGNED TO LIE |
| Wednesday, June 11, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 25, 2014 | REFUSAL PROCESSED BY IB |
| Tuesday, March 25, 2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, March 25, 2014 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 25, 2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, March 24, 2014 | NON-FINAL ACTION WRITTEN |
| Monday, March 24, 2014 | ASSIGNED TO EXAMINER |
| Tuesday, February 4, 2014 | APPLICATION FILING RECEIPT MAILED |
| Friday, January 31, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 30, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |